Ontology highlight
ABSTRACT:
SUBMITTER: Schwendenwein A
PROVIDER: S-EPMC7917449 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
Schwendenwein Anna A Megyesfalvi Zsolt Z Barany Nandor N Valko Zsuzsanna Z Bugyik Edina E Lang Christian C Ferencz Bence B Paku Sandor S Lantos Andras A Fillinger Janos J Rezeli Melinda M Marko-Varga Gyorgy G Bogos Krisztina K Galffy Gabriella G Renyi-Vamos Ferenc F Hoda Mir Alireza MA Klepetko Walter W Hoetzenecker Konrad K Laszlo Viktoria V Dome Balazs B
Molecular therapy oncolytics 20210206
Small cell lung cancer (SCLC; accounting for approximately 13%-15% of all lung cancers) is an exceptionally lethal malignancy characterized by rapid doubling time and high propensity to metastasize. In contrast to the increasingly personalized therapies in other types of lung cancer, SCLC is still regarded as a homogeneous disease and the prognosis of SCLC patients remains poor. Recently, however, substantial progress has been made in our understanding of SCLC biology. Advances in genomics and d ...[more]